What is the recommended treatment for pseudogout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pseudogout

For acute pseudogout attacks, NSAIDs at full anti-inflammatory doses are first-line when there are no contraindications, while low-dose oral corticosteroids or intra-articular steroid injection should be prioritized in elderly patients or those with NSAID contraindications. 1

Acute Attack Management

First-Line Options Based on Patient Characteristics

For patients without contraindications to NSAIDs:

  • Use NSAIDs at full anti-inflammatory doses as the initial treatment 1
  • Treatment should be initiated within 24 hours of symptom onset for optimal efficacy 1
  • NSAIDs are particularly effective but carry risks of gastrointestinal bleeding and cardiovascular toxicity, especially in elderly patients 1

For elderly patients or those with NSAID contraindications:

  • Low-dose oral corticosteroids are the preferred first-line option due to their favorable safety profile 2, 1
  • Intra-articular aspiration followed by long-acting steroid injection is particularly safe and effective, avoiding systemic medication risks 2, 1
  • This approach is especially useful for monoarticular or oligoarticular disease affecting accessible joints 1

Alternative acute treatment:

  • Low-dose colchicine (0.5-0.6 mg two to three times daily) is effective with fewer gastrointestinal side effects than traditional high-dose regimens 1
  • Avoid high-dose colchicine as it leads to significant gastrointestinal toxicity without additional benefit 1

Polyarticular Attacks

For patients with multiple joint involvement:

  • Intramuscular triamcinolone acetonide 60 mg is safe, well-tolerated, and effective when intra-articular injections are impractical 3
  • A second injection may be given on Day 1-2 if inadequate response occurs 3
  • Major clinical improvement typically occurs by Day 3-4 3

Long-Term Management

Unlike gout, pseudogout has no equivalent to urate-lowering therapy, so long-term management focuses on preventing recurrent attacks and treating underlying conditions 2

Prophylactic Therapy for Frequent Recurrent Attacks

For patients with frequent flares:

  • Low-dose colchicine (0.5-0.6 mg once or twice daily) is the preferred prophylactic agent 1
  • If colchicine is contraindicated, use low-dose NSAIDs with gastric protection 1
  • If both colchicine and NSAIDs are contraindicated, use low-dose corticosteroids (<10 mg/day) 1

Addressing Underlying Conditions

Evaluate and manage contributing factors:

  • If the patient is on diuretic therapy, consider stopping the diuretic if possible to reduce attack risk 2
  • Address comorbidities including hypertension, hyperlipidemia, and hyperglycemia 2, 1
  • These interventions improve overall patient outcomes and may reduce pseudogout frequency 2

Adjuvant and Supportive Measures

Additional interventions to optimize outcomes:

  • Apply topical ice packs for pain relief during acute flares 2
  • Provide patient education about the condition, including weight loss if obese, dietary modifications, and reduced alcohol consumption 1
  • Regular follow-up to assess for recurrent attacks and adjust prophylactic therapy as needed 1

Common Pitfalls to Avoid

Critical considerations for safe and effective treatment:

  • Do not use high-dose colchicine regimens; low doses are sufficient and better tolerated 1
  • Be cautious with NSAIDs in elderly patients due to increased risk of gastrointestinal and cardiovascular complications 1
  • Do not delay treatment; efficacy is optimized when therapy begins within 24 hours of symptom onset 1
  • Remember that unlike gout, there is no disease-modifying therapy for pseudogout, so focus remains on acute and prophylactic anti-inflammatory management 2, 4

References

Guideline

Treatment for Pseudogout

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pseudogout Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.